Clinical trial
Azacitidine to Restore Thyroid Function in Patients With Persistent or…
NCT00004062 · Lucille P. Markey Cancer Center at University of Kentucky, Other · Completed
Key facts
| NCT number | NCT00004062 |
|---|---|
| Title | Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer |
| Official title | Restoration of Radioiodine Uptake in Thyroid Carcinoma: A Clinical Trial |
| Lead sponsor | Lucille P. Markey Cancer Center at University of Kentucky, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | azacitidine, liothyronine sodium, iodine I 131 |
| Start date | Jul 1, 1999 |
| Completion | Aug 1, 2006 |
| First posted | Jun 4, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: